160 related articles for article (PubMed ID: 36799474)
1. Trigred motif 36 regulates neuroendocrine differentiation of prostate cancer via HK2 ubiquitination and GPx4 deficiency.
Zhao X; Zhou T; Wang Y; Bao M; Ni C; Ding L; Sun S; Dong H; Li J; Liang C
Cancer Sci; 2023 Jun; 114(6):2445-2459. PubMed ID: 36799474
[TBL] [Abstract][Full Text] [Related]
2. Androgen-responsive tripartite motif 36 enhances tumor-suppressive effect by regulating apoptosis-related pathway in prostate cancer.
Kimura N; Yamada Y; Takayama KI; Fujimura T; Takahashi S; Kume H; Inoue S
Cancer Sci; 2018 Dec; 109(12):3840-3852. PubMed ID: 30238687
[TBL] [Abstract][Full Text] [Related]
3. Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2).
Jiao L; Zhang HL; Li DD; Yang KL; Tang J; Li X; Ji J; Yu Y; Wu RY; Ravichandran S; Liu JJ; Feng GK; Chen MS; Zeng YX; Deng R; Zhu XF
Autophagy; 2018; 14(4):671-684. PubMed ID: 28980855
[TBL] [Abstract][Full Text] [Related]
4. TRIM36 enhances lung adenocarcinoma radiosensitivity and inhibits tumorigenesis through promoting RAD51 ubiquitination and antagonizing hsa-miR-376a-5p.
Yu S; Li W; Liu X; Zhang H; Liu X; Zhang LW
Biochem Biophys Res Commun; 2022 Nov; 628():1-10. PubMed ID: 36058131
[TBL] [Abstract][Full Text] [Related]
5. Pyruvate kinase L/R links metabolism dysfunction to neuroendocrine differentiation of prostate cancer by ZBTB10 deficiency.
Wen YC; Chen WY; Tram VTN; Yeh HL; Chen WH; Jiang KC; Abou-Kheir W; Huang J; Hsiao M; Liu YN
Cell Death Dis; 2022 Mar; 13(3):252. PubMed ID: 35306527
[TBL] [Abstract][Full Text] [Related]
6. Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer.
Enriquez C; Cancila V; Ferri R; Sulsenti R; Fischetti I; Milani M; Ostano P; Gregnanin I; Mello-Grand M; Berrino E; Bregni M; Renne G; Tripodo C; Colombo MP; Jachetti E
Cancer Res; 2021 Aug; 81(16):4257-4274. PubMed ID: 34185677
[TBL] [Abstract][Full Text] [Related]
7. Non-proteolytic ubiquitination of Hexokinase 2 by HectH9 controls tumor metabolism and cancer stem cell expansion.
Lee HJ; Li CF; Ruan D; He J; Montal ED; Lorenz S; Girnun GD; Chan CH
Nat Commun; 2019 Jun; 10(1):2625. PubMed ID: 31201299
[TBL] [Abstract][Full Text] [Related]
8. AMPK/SIRT1 signaling through p38MAPK mediates Interleukin-6 induced neuroendocrine differentiation of LNCaP prostate cancer cells.
Natani S; Dhople VM; Parveen A; Sruthi KK; Khilar P; Bhukya S; Ummanni R
Biochim Biophys Acta Mol Cell Res; 2021 Sep; 1868(10):119085. PubMed ID: 34171447
[TBL] [Abstract][Full Text] [Related]
9. Validation of SV2A-Targeted PET Imaging for Noninvasive Assessment of Neuroendocrine Differentiation in Prostate Cancer.
Guan B; Zhou N; Wu CY; Li S; Chen YA; Debnath S; Hofstad M; Ma S; Raj GV; He D; Hsieh JT; Huang Y; Hao G; Sun X
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884893
[TBL] [Abstract][Full Text] [Related]
10. FOXA2 Suppression by TRIM36 Exerts Anti-Tumor Role in Colorectal Cancer Via Inducing NRF2/GPX4-Regulated Ferroptosis.
Liu X; Yan C; Chang C; Meng F; Shen W; Wang S; Zhang Y
Adv Sci (Weinh); 2023 Dec; 10(35):e2304521. PubMed ID: 37875418
[TBL] [Abstract][Full Text] [Related]
11. A novel GRK3-HDAC2 regulatory pathway is a key direct link between neuroendocrine differentiation and angiogenesis in prostate cancer progression.
Naderinezhad S; Zhang G; Wang Z; Zheng D; Hulsurkar M; Bakhoum M; Su N; Yang H; Shen T; Li W
Cancer Lett; 2023 Sep; 571():216333. PubMed ID: 37543278
[TBL] [Abstract][Full Text] [Related]
12. The Neuropilin-1/PKC axis promotes neuroendocrine differentiation and drug resistance of prostate cancer.
Blanc C; Moktefi A; Jolly A; de la Grange P; Gay D; Nicolaiew N; Semprez F; Maillé P; Soyeux P; Firlej V; Vacherot F; Destouches D; Amiche M; Terry S; de la Taille A; Londoño-Vallejo A; Allory Y; Delbé J; Hamma-Kourbali Y
Br J Cancer; 2023 Mar; 128(5):918-927. PubMed ID: 36550208
[TBL] [Abstract][Full Text] [Related]
13. Activation of TGF-β - SMAD2 signaling by IL-6 drives neuroendocrine differentiation of prostate cancer through p38MAPK.
Natani S; Sruthi KK; Asha SM; Khilar P; Lakshmi PSV; Ummanni R
Cell Signal; 2022 Mar; 91():110240. PubMed ID: 34986386
[TBL] [Abstract][Full Text] [Related]
14. Involvement of EZH2 in aerobic glycolysis of prostate cancer through miR-181b/HK2 axis.
Tao T; Chen M; Jiang R; Guan H; Huang Y; Su H; Hu Q; Han X; Xiao J
Oncol Rep; 2017 Mar; 37(3):1430-1436. PubMed ID: 28184935
[TBL] [Abstract][Full Text] [Related]
15. PARP Inhibition Suppresses GR-MYCN-CDK5-RB1-E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer.
Liu B; Li L; Yang G; Geng C; Luo Y; Wu W; Manyam GC; Korentzelos D; Park S; Tang Z; Wu C; Dong Z; Sigouros M; Sboner A; Beltran H; Chen Y; Corn PG; Tetzlaff MT; Troncoso P; Broom B; Thompson TC
Clin Cancer Res; 2019 Nov; 25(22):6839-6851. PubMed ID: 31439587
[TBL] [Abstract][Full Text] [Related]
16. IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation.
Feng T; Wang J; Cheng K; Lu Q; Zhao R; Wang S; Zhang Q; Ge L; Pan J; Song G; Wang L
Cancer Biol Med; 2021 Oct; 19(7):1008-28. PubMed ID: 34652890
[TBL] [Abstract][Full Text] [Related]
17. Autophagy pathway is required for IL-6 induced neuroendocrine differentiation and chemoresistance of prostate cancer LNCaP cells.
Chang PC; Wang TY; Chang YT; Chu CY; Lee CL; Hsu HW; Zhou TA; Wu Z; Kim RH; Desai SJ; Liu S; Kung HJ
PLoS One; 2014; 9(2):e88556. PubMed ID: 24551118
[TBL] [Abstract][Full Text] [Related]
18. TRIM59 is suppressed by androgen receptor and acts to promote lineage plasticity and treatment-induced neuroendocrine differentiation in prostate cancer.
Fan L; Gong Y; He Y; Gao WQ; Dong X; Dong B; Zhu HH; Xue W
Oncogene; 2023 Feb; 42(8):559-571. PubMed ID: 36544044
[TBL] [Abstract][Full Text] [Related]
19. TRIM36 suppresses cell growth and promotes apoptosis in human esophageal squamous cell carcinoma cells by inhibiting Wnt/β-catenin signaling pathway.
Zhao B; Qiao G; Li J; Wang Y; Li X; Zhang H; Zhang L
Hum Cell; 2022 Sep; 35(5):1487-1498. PubMed ID: 35768649
[TBL] [Abstract][Full Text] [Related]
20. TRIM59 knockdown blocks cisplatin resistance in A549/DDP cells through regulating PTEN/AKT/HK2.
He R; Liu H
Gene; 2020 Jul; 747():144553. PubMed ID: 32165307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]